Anatomical Pathology Collagen Peptide

Document Sample
Anatomical Pathology Collagen Peptide Powered By Docstoc
					American Society for Clinical Pathology
2004 Resident In-Service Examination
Item Descriptors

                                                Anatomical Pathology
1.      Desmoid-type fibromatosis; no metastatic potential
2.      Hodgkin's disease; fine-needle aspirate neck
3.      Mesothelial cell; staining pattern
4.      Papillary carcinoma; aspirate thyroid nodule
5.      Chromagranin; fine-needle aspiration liver
6.      Mesothelial cells; effusions
7.      Fine-needle aspiration biopsy; nodular fasciitis
8.      Carcinoma of breast; intracytoplasmic lumens
9.      Radiation effect; Pap smear
10.     Cervical smears; tissue sections
11.     High grade squamous intraepithelial lesion; Pap smear
12.     Atypical squamous cells of undetermined significance; reporting definition
13.     Carcinoma; fine-needle aspiration of breast mass
14.     Subareolar abscess of the breast; ruptured epidermal inclusion cyst
15.     Meningioma; fine-needle aspiration of a scalp lesion
16.     Adenocarcinoma in situ; Pap smear
17.     Colloid carcinoma; fine-needle aspirate breast
18.     Bilateral mass; fine-needle aspirate breast
19.     Reserve cells; small cell undifferentiated carcinoma
20.     Bronchioalveolar carcinoma; fine-needle aspiration lung
21.     Follicle center lymphoma; fine-needle aspiration lymph nodes
22.     Aspirate of solitary thyroid nodule; lesion excised
23.     Busulfan; mimic cancer
24.     Course of acyclovir; Pap smear
25.     Cryptococcus neoformans; fluid aspirated thigh abscess
26.     Warthin's tumor; bilateral parotid tumor
27.     Gleason pattern3+4; prostatic adenocarcinoma
28.     Contamination; urine cytology specimen
29.     Sarcomatoid renal carcinoma; any histologic type
30.     Chromophobe renal carcinoma; outcome
31.     Renal carcinoma; t(X;1) (p11.2;q21) chromosome translocation
32.     Endometrial cells; Bethesda
33.     Intractable gastric ulcers duodenal wall mass; peripancreatic lymph node
34.     Benign mixed tumor; fine-needle aspiration jaw
35.     Warthin tumor; fine-needle aspiration parotid
36.     Small cell carcinoma; sputum

Forensic Pathology
37.      Hypothermia; Anatomic findings
38.      Stomach contents; cocaine toxicity
39.      Incised wound; laceration
40.      Designer drugs; modifying the structure
41.      Gunshot wound; exit
42.      Postmortem change; lesions
43.      Atlantooccipital dislocation; vehicle accident death
44.      Vitreous fluid; hyperglycemia
45.      Drowning; other causes of death
46.      Ateriosclerotic heart disease; sudden and unexpected death
47.      Postmortem interval; > 16 hours
48.      Temporal and frontal lobe contusions; fall on the back of the head
49.      Gunshot wound; high velocity military rifle
50.      Injury on the arm; bite mark impression
51.      Sudden infant death syndrome; heart
52.      Man without a spleen; Gram stain of meninges
53.      Manual strangulation; fracture of the hyoid bone
54.      Homicide; manner of death
55.      Mechanism of death; septicemia

Surgical Pathology
56.      Paget’s disease; regional carcinoma
57.      Thyroid cancer; age
58.      Breast neoplasms; worst prognosis
59.      Intramuscular myxoma; gelatinous tumor of the thigh
60.      Gynecomastia; Ultrastructural features
61.      Intratubular germ cell neoplasia; placental alkaline phosphatase
62.      Anogenital verrucous carcinoma; description
63.      Renomedullary interstitial cell tumor
64.      Renal artery; Fibromuscular dysplasia
65.      Adenocarcinoma of the urinary bladder; enteric carcinomas
66.      Erythema nodosum; characterization
67.      Contact allergy; Lichenoid interface dermatitis
68.      Progressive multifocal leukoencephalopathy; characteristics
69.      Fibroadenoma of the breast; greatest incidence
70.      Mulitcystic renal dysplasia; renal mass, primitive ducts
71.      Dermatofibrosarcoma protuberans; CD34 positive
72.      Subacute sclerosing panencephalitis; slowly progressive neurodegenerative disease
73.      Osteoblastoma; flat bones
74.      Dermatitis herpetiformis; gluten-sensitive enteropathy
75.      Colon biopsy; labeling of collagen
76.      Pulmonary lesion; lumen of a large airway
77.      Seminoma
78.      Cervical tunnel clusters; dilated endocervical glands
79.      Testicular tumor; 1-year-old
80.      Solitary fibrous tumor of pleura; increased recurrence
81.      Familial adenomatous polyposis syndrome; genetic abnormality
82.      Ground glass hepatocytes; Hepatitis B
83.      Malakoplakia; Escherichia coli
84.      Primary sclerosing cholangitis; primary biliary cirrhosis
85.      Metastatic papillary cancer; good prognosis
86.      Hashimoto's thyroiditis; thyromegaly
87.      Giant cell (temporal) arthritis; Associated findings
88.      Pure hepatic canalicular cholestasis; sepsis
89.      Adenomatoid tumor
90.      Cerebral hematoma metastatic tumor; beta HCG
91.      Kaposi's sarcoma; multiple organs
92.      Biopsy from the great toe; polarized light
93.      Cervical lymph node biopsy; Epstein Barr-virus testing
94.      Enchondroma; low grade central chondrosarcoma
95.      Gastrectomy specimen; ascites and bilateral ovarian masses
96.      Osteoarthritis; femoral head
97.      Yelloe fever; necrosis
98.      Small intestinal tumor; interstitial cells of Cajal
99.      Low grade sil; eventual regression
100.     Gastrointestinal tract dysplasia; unequivocally neoplastic epithelium
101.     Gallbladder; stones
102.     Adenocarcinoma of the lung; predictor of survival
103.     Invasive mammary carcinoma; appearance
104.     Liposarcomas; prognostic indicator
105.     Thymoma; myasthenia gravis
106.     Polymorphous low-grade adenocarcinoma of minor salivary gland; oral cavity
107.     Lobular carcinoma of the breast; Classic-type invasive
108.     Pseudoangiomatous change; breast
109.     Inflammatory breast cancer; dermal lymphatic invasion
110.     Osteoid osteoma; osteoblastoma
111.     Common primary malignant neoplasm; malignant fibrous histiocytoma
112.     Nodular fasciitis; characteristics
113.     Epithelioid sarcoma; positive for cytokeratins
114.     Esophagitis; mid-esophagus biopsy
115.     Crohn's disease; a gastric biopsy
116.     Anti-gliadin antibodies; lymphocytic colitis

117.     Peutz-Jehger's polyposis; small bowel
118.     Jejuno-ileal carcinoid tumors; fibroblastic reaction
119.     Ulcerative colitis; biopsies
120.     Colon biopsies; H&E and trichrome-stained
121.     Focal nodular hyperplasia; young women
122.     Genetic hemochromatosis; stainable iron
123.     Primary sclerosing cholangitis; cholangiocarcinoma
124.     Esophageal adenocarcinoma; gastroesophageal reflux
125.     Helicobacter pylori gastritis; atrophic gastritis
126.     Gastric adenocarcinoma; atrophic gastritis
127.     Gastric stromal tumors; c-kit gene

                                                   Clinical Pathology
Clinical Chemistry
128       Major intracellular cation; K+
129.      Prostate specific antigen; monitoring
130.      Serum osmolality; calculation
131.      Transthyretin; nutritional status
132.      Distal renal tubular acidosis; normal anion gap
133.      Loop diuretics; mechanism
134.      Methanol ingestion; serum osmole gap
135.      LDL cholesterol levels; 160 mg/dL
136.      LDL subclasses; Higher risk
137.      PKU; screening tests
138.      Pituitary gland; prolactin secreting tumor
139.      Method comparison; precision
140.      Fetal fibronectin; negative
141.      Diabetes Mellitus; Fructosamine
142.      Acute leukemia; elevated potassium
143.      Sensitivity of MCV; screen iron deficiency
144.      Distribution of the values: 25th percentile
145.      NT-proBNP: description
146.      Linearity; regression
147.      Cholesterol; maximum bias
148.      CML in blast crisis; glucose
149.      Fasting hypoglycemia; C-peptide
150.      Blunt head trauma; distinguishing fluids
151.      Canavan disease; mutation in aspartoacylase
152.      Fetal fibronectin; preterm labor
153.      Nitric oxide; peroxynitric acid
154.      BNP; congestive heart failure
155.      Drugs of abuse; metabolite of crack cocaine
156.      High-sensitivity C-reactive protein; levels of >15 mg/L indicate active inflammation
157.      Circulating alkaline phosphatase; condition

159.   Hodgkin’s disease; lymph node excision
160.   Plasma cell leukemia; peripheral blood smear
161.   Sickle cell disease; hemoglobin electrophoresis patterns
162.   Small megakaryocytes; chronic myelogenous leukemia
163.   Abetalipoproteinemia; peripheral blood smear
164.   Chronic myelomonocytic leukemia; peripheral blood smear
165.   Anemia of chronic disease; lymphadenopathy
166.   Plasma cell myeloma; WHO
167.   Severe neutropenia in the neonatal age; bacterial sepsis
168.   chronic myelogenous leukemia; absolute basophilia
169.   Chloroacetate esterase; myeloid sarcoma
170.   Beta-thalassemia trait; hemoglobin A2
171.   Hyperdiploid karyotype; peripheral blood slide
172.   Toxoplasmosis; lymph node

173.     Mantle cell lymphoma; CD5-expression
174.     CD15 positive neoplastic cells; slide
175.     Monoclonal chronic large granular lymphocyte proliferations; neutropenia
176.     Acute lymphoytic leukemia; cytochemical reactions
177.     Hairy cell leukemia; tartrate-resistant acid phosphatase
178.     Thrombotic thrombocytopenic purpura; platelet count
179.     Refractory anemia; peripheral blood smear and laboratory studies
180.     S-beta thalassemia; hemoglobin electrophoresis
181.     Platelet function; inhibition
182.     Bernard-Soulier disease; platelet aggregation study
183.     Essential thrombocythemia; platelet count
184.     B-cell lymphoma; immunoglobulin
185.     Post-transfusion purpura; P1A1 antigen
186.     B-cells; Hairy cell leukemia
187.     Cold agglutinin disease; red cell finding
188.     Alder-Reilly anomaly; mucopolysaccharidoses
189.     Thrombotic thrombocytopenic purpura; pathogenesis
190.     Factor XII deficiency; bleeding risk
191.     Liver disease; coagulation results
192.     Viral infection; blood smear shown
193.     Osteoblasts; bone marrow smear
194.     Chediak-Higashi syndrome; peripheral blood smear
195.     Thrombotic thrombocytopenic purpura; blood smear
196.     Specimen requirement for CBC; Quality Control
197.     Spleen; PAS/diastase stains
198.     Mean cell volume (MCV); hyperglycemia
199.     nemias Hemolytic
200.     Megaloblastic anemia; bone marrow aspirate smear
201.     Prothrombin G20210A mutation; predispositions
202.     Hereditary bleeding disorder; von Willebrand disease
203.     Platelet glycoprotein Ib; von Willebrand factor

204.    Coxsackieviruses; persistent viral infection
205.    Susceptibility testing; disk selection
206.    Listeria; gram positive bacillus
207.    Staphylococcus aureus; coagulase test
208.    Staphylococcus aureus; colony characterizations
209.    Prevotella intermedi; pleural fluid
210.    Granulomatous dermatitis; microscopic appearance
211.    Anaplasma phagocytophilia; human granulocytic ehrilichiosis (HE)
212.    Rickettsia rickettssii; camping trip
213.    Staphylococcus aureus; mec A gene
214.    FTA-ABS test; Treponema pallidum
215.    Streptococcus pyogenes; blood culture slide
216.    Enterococcus faecalis; blood culture slide
217.    Stool assay; post-antibiotic diarrhea
218.    Ascaris lumbricoides; cysticercosis
219.    Highly pathogenic; non immunocompromised human hosts
220.    Bartonella henselae; cat scratch disease
221.    Pneumocococus; erythromycin resistance
222.    Mycobacterium tuberculosis; nitrate positive
223.    Trichophyton species; infections of hair follicles
224.    Penicillin resistant S. pneumoniae; oxacillin disk
225.    Parvovirus B19; "fifth's" disease
226.    Clostridium difficile toxin assays; hospitalized adult patient
227.    Neonate sepsis; blood culture
228.    Bovine spongioform encephalopathy; Creutzfeldt-Jacob disease
229.    Epstein-Barr virus infection; post-transplant lymphoproliferative disorders
230.    Malarial infection; red blood cell morphologic alterations
231.    Colonic spirochetosis; identified histologically
232.    Toxoplasma encephalitis; multifocal necrotizing lesions

233.     Cryptococcal meningitis; CSF titers of cryptococcal antigen
234.     Cytomegalovirus; Latent infection
235.     SARS; Coronavirus
236.     West Nile Virus; meningoencephalitis
237.     Food-borne infections; screening
238.     Anaerobe specimens; synovial fluid
239.     Enterobius vermicularis; Cellulose tape preparations
240.     Actinomyces israelii; oral surgery

Transfusion Medicine
241.     Irradiation of Blood; CMV
242.     Red blood cell preservative or; approved shelf life
243.     Plasmapheresis for TTP; replacement solution
244.     Cord red blood cells; Lea
245.     Transfusion records; FDA
246.     Dosage; Kidd
247.     Gamma irradiation; GVHD
248.     Cold-reactive agglutinin; anti-I
249.     TRALI; pulmonary edema
250.     Autologous donor; Requirements
251.     Plasmodium vivax; Fy(a-b-)
252.     Transfusion reaction; additional transfusions
253.     Platelet pheresis donors; Requirement
254.     HLA-identical match; siblings
255.     Enzyme treatment; S antigen
256.     Donor reaction; treatment is
257.     Blood preservation; pH
258.     Massively transfused patient; bleeding
259.     HIV infections; EIA-detectable antibodies
260.     Critical titer of anti-D; amniocentesis
261.     TRALI; anti-leukocyte antibodies
262.     Leukocyte-reduced Red Blood Cells; cytomegalovirus
263.     Infectious mononucleosis; anti-I
264.     Massive transfusion; platelet transfusion
265.     Donor Collection; additional blood
266.     Chronic Transfusion; chelators
267.     Anti-K and anti-Fya; Enzyme techniques
268.     Malaria; Haiti
269.     Antithetical platelet antigens; GPIIIa
270.     Rh null phenotype; stomatocytes
271.     Plasma products; expiration
272.     Bleeding complications; central line placement
273.     Anti-M; glycophorin A
274.     Apheresis catheter placement; patient management
275.     Cryoprecipitate; minimum factor
276.     Mislabeled Specimen; RBC unit issue
277.     Lewis antibody; first pregnancy
278.     Granulocyte transfusion; graft versus host disease
279.     T cell depletion; engraftment failure
280.     Blood component preparation; order of steps

                                                Special Topics
281.   Paroxysmal nocturnal hemoglobinuria; Ham's test
282.   Immunofluorescence Lupus Band Test; skin
283.   IgA molecules; placenta
284.   IgA deficiency; Caucasians
285.   Severe renal pathology; autoantibody
286.   Silicone breast implants; autoimmune disease
287.   Bence Jones protein; chemical structure
288.   Anti-mitochondrial antibody; symptoms
289.   Acute-phase reaction; indicator

290.     C-reactive protein; pneumoccocal C-polysaccharide
291.     Acute-phase reaction; electrophoresis
292.     Systemic vasculitis; abnormal serologic test
293.     CREST variant of scleroderma; anti-centromere antibody
294.     HIV disease Monitoring; CD34 enumeration
295.     Acute leukemias; immunophenotypic analysis
296.     Hemoglobin F; replacement assay
297.     Linear deposition of IgG and C3; Bullous pemphigoid
298.     Amyotrophic lateral sclerosis; superoxide dismutase-1 (SOD-1) gene
299.     Huntington's chorea; trinucleotide repeat disorder

Laboratory Administration
300.    Maslow; highest level
301.    Motivation technique; empowerment
302.    Accrediting organization; JCAHO
303.    CLIA waived tests; FDA review
304.    Internet connection; T1
305.    Archive hypertext documents; CD-RW
306.    Retention of laboratory reports; time requirements
307.    Current Procedural Terminology; code for a medical procedure or service
308.    Flow chart; symbol
309.    Medicare Part B reimbursement; pathologist services
310.    Specimen referral; illegal
311.    Laboratory employees; Hepatitis B vaccine
312.    majority of tests; type of laboratory
313.    Medicare; billing notification

Special Techniques
314.     Flow cytometry; lymphocyte scatter
315.     HLA type; disease association
316.     Angioimmunoblastic lymphadenopathy; gene rearrangements
317.     Mantle cell lymphoma; phenotypic marker
318.     Acute myelogenous leukemia; retinoic acid therapy
319.     Anaplastic large cell lymphoma; CD30 positivity and t(2;5) translocation
320.     Synovial sarcoma; t(X;18)(p11;q11)
321.     Fragile X syndrome; trinucleotide expansion disease
322.     Hairy cell leukemia; CD11c, CD22, CD25, and CD103
323.     Myelodysplastic syndromes; chromosome changes
324.     Multiple Endocrine Neoplasia type 2; RET gene
325.     Inherited thrombophilia; factor V Leiden mutation


Shared By:
Description: Anatomical Pathology Collagen Peptide